JP4101874B2 - イムノアッセイ用試薬の緩衝剤組成物 - Google Patents

イムノアッセイ用試薬の緩衝剤組成物 Download PDF

Info

Publication number
JP4101874B2
JP4101874B2 JP50073897A JP50073897A JP4101874B2 JP 4101874 B2 JP4101874 B2 JP 4101874B2 JP 50073897 A JP50073897 A JP 50073897A JP 50073897 A JP50073897 A JP 50073897A JP 4101874 B2 JP4101874 B2 JP 4101874B2
Authority
JP
Japan
Prior art keywords
acid
composition
biological
antibodies
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP50073897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001516440A (ja
JP2001516440A5 (https=
Inventor
フイガード，ステイーブ・デイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2001516440A publication Critical patent/JP2001516440A/ja
Publication of JP2001516440A5 publication Critical patent/JP2001516440A5/ja
Application granted granted Critical
Publication of JP4101874B2 publication Critical patent/JP4101874B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
JP50073897A 1995-06-07 1996-05-24 イムノアッセイ用試薬の緩衝剤組成物 Expired - Lifetime JP4101874B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/482,710 1995-06-07
US08/482,710 US5616460A (en) 1995-06-07 1995-06-07 Buffer composition for reagents for immunoassay
PCT/US1996/007745 WO1996041164A1 (en) 1995-06-07 1996-05-24 Buffer composition for reagents for immunoassay

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005139663A Division JP3930519B2 (ja) 1995-06-07 2005-05-12 イムノアッセイ用試薬の緩衝剤組成物

Publications (3)

Publication Number Publication Date
JP2001516440A JP2001516440A (ja) 2001-09-25
JP2001516440A5 JP2001516440A5 (https=) 2004-07-08
JP4101874B2 true JP4101874B2 (ja) 2008-06-18

Family

ID=23917128

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50073897A Expired - Lifetime JP4101874B2 (ja) 1995-06-07 1996-05-24 イムノアッセイ用試薬の緩衝剤組成物
JP2005139663A Expired - Lifetime JP3930519B2 (ja) 1995-06-07 2005-05-12 イムノアッセイ用試薬の緩衝剤組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005139663A Expired - Lifetime JP3930519B2 (ja) 1995-06-07 2005-05-12 イムノアッセイ用試薬の緩衝剤組成物

Country Status (7)

Country Link
US (2) US5616460A (https=)
EP (1) EP0852009B1 (https=)
JP (2) JP4101874B2 (https=)
AT (1) ATE223046T1 (https=)
DE (1) DE69623303T2 (https=)
ES (1) ES2184866T3 (https=)
WO (1) WO1996041164A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
EP0999853B1 (en) * 1997-06-13 2003-01-02 Genentech, Inc. Stabilized antibody formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
ATE417275T1 (de) 1997-09-22 2008-12-15 Novartis Vaccines & Diagnostic Puffern zur stabilizierung von hcv antigenen
AU9497998A (en) 1997-09-22 1999-04-12 Chiron Corporation Method for detecting antibodies in a sample
BRPI9909678B8 (pt) * 1998-04-17 2021-05-25 Fujirebio Europe N V aperfeiçoados ensaios de imunodiagnóstico usando agentes redutores
US6623921B2 (en) 1998-07-30 2003-09-23 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
US7316905B1 (en) 1998-07-30 2008-01-08 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
DE10013794A1 (de) * 2000-03-15 2001-10-11 Gluesenkamp Karl Heinz Herstellung, Stabilisierung und Anwendung einer neuen Art von chemisch aktivierten Oberflächen
AU2001273264A1 (en) * 2000-07-21 2002-02-05 Cuno, Incorporated Improved blocking chemistries for nylon membrane
AU2001287423B2 (en) * 2000-08-21 2007-04-05 Queen's University At Kingston Methods and kits for separation and detection of proteins in biological samples
US20030170618A1 (en) * 2001-02-02 2003-09-11 Chien David Y. Buffers for stabilizing antigens
AU785380B2 (en) * 2001-03-28 2007-03-15 Ortho-Clinical Diagnostics, Inc. A hepatitis C antigen - antibody combination assay for the early detection of HCV infection
JP2003066047A (ja) * 2001-06-14 2003-03-05 Matsushita Electric Ind Co Ltd 免疫反応測定方法及びそれに用いる免疫反応測定用試薬
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
CH698246B1 (de) * 2001-12-20 2009-06-30 Hoffmann La Roche Test zur Identifizierung von Inhibitoren von Beta-Sekretasen.
US20030157556A1 (en) * 2002-02-13 2003-08-21 Maggiore Jack A. Biological fluid stabilizing composition and method of use thereof
AU2003238767A1 (en) * 2002-05-31 2003-12-19 Penn State Research Foundation Dot-elisa for the detection of animal viruses
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
CA2544185C (en) * 2003-10-28 2010-09-28 Advanced Life Science Institute, Inc. Method of detecting hepatitis c virus
CN104090097B (zh) * 2004-02-26 2017-04-12 康多尔生物技术有限公司 一种用作结合对的特异性结合反应培养基的水溶液
ATE476658T1 (de) 2004-02-26 2010-08-15 Candor Bioscience Gmbh Wässrige lösung zur verwendung als medium für die spezifischen bindungsreaktion eines bindespaares
US7867443B2 (en) * 2004-07-23 2011-01-11 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
JP2007084579A (ja) * 2006-12-28 2007-04-05 Mitsubishi Pharma Corp ヘパリン溶液入りプレフィルドシリンジ製剤およびその製造方法
US8617820B2 (en) * 2007-08-28 2013-12-31 Ortho-Clinical Diagnostics, Inc. Use of glycosaminoglycans to reduce non-specific binding in immunoassays
JP5416159B2 (ja) * 2011-03-31 2014-02-12 富士フイルム株式会社 高感度なイムノクロマトグラフ方法
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
WO2016127318A1 (zh) * 2015-02-10 2016-08-18 深圳市新产业生物医学工程股份有限公司 心肌肌钙蛋白i超敏检测试剂盒及其超敏检测方法
US12493034B2 (en) * 2021-01-08 2025-12-09 George Mason University Reagent buffer
CN114200125B (zh) * 2021-12-06 2024-02-13 武汉生之源生物科技股份有限公司 一种不含蛋白的碱性磷酸酶-抗体偶联物稀释液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198999A (ja) * 1983-04-27 1984-11-10 Denka Seiken Co Ltd クレアチンキナ−ゼ測定用組成物
JPS6339582A (ja) * 1986-08-04 1988-02-20 Takara Shuzo Co Ltd 酵素組成物
US4956274A (en) * 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
US5075221A (en) * 1988-10-07 1991-12-24 Eastman Kodak Company Stabilized extraction composition containing a sulfhydryl-containing reducing agent and its use in chlamydial and gonococcal determinations
EP0401379B1 (en) * 1988-12-06 1994-06-15 Otsuka Pharmaceutical Co., Ltd. STABILIZED COMPOSITION OF INTERLEUKIN-1$g(b)
CA2079912C (en) * 1990-04-06 2000-07-11 Gregory Reyes Hepatitis c virus epitopes
AU2679492A (en) * 1991-09-16 1993-04-27 Abbott Laboratories Hepatitis c assay
US5376313A (en) * 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
GR1001480B (el) * 1992-12-29 1994-02-28 Eyaggelia Protopapa Ενζυμικά σκευάσματα περιέχοντα παπαϊνη ή χυμο?ρυψίνη και μέ?οδοι μόνιμης ενζυμικής αποτρίχωσης.

Also Published As

Publication number Publication date
EP0852009A1 (en) 1998-07-08
JP2005300552A (ja) 2005-10-27
JP2001516440A (ja) 2001-09-25
DE69623303T2 (de) 2003-04-17
WO1996041164A1 (en) 1996-12-19
JP3930519B2 (ja) 2007-06-13
DE69623303D1 (de) 2002-10-02
ES2184866T3 (es) 2003-04-16
EP0852009B1 (en) 2002-08-28
ATE223046T1 (de) 2002-09-15
US5773212A (en) 1998-06-30
US5616460A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
JP4101874B2 (ja) イムノアッセイ用試薬の緩衝剤組成物
JP3884652B2 (ja) ポリペプチドおよび抗原の安定化希釈液
EP1801591B1 (en) Methods for detection or measurement of viruses
JPS632348B2 (https=)
JP4097191B2 (ja) Ｈｃｖ−特異的ペプチドおよびそれらの使用
JP3510232B2 (ja) ウイルスの検出又は測定方法
NZ504710A (en) Chromatography assay for the detection of analytes in blood
JP3398199B2 (ja) 塩基解離アッセイ
JPH0220945B2 (https=)
AU632271B2 (en) Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
CA1278259C (en) Competitive elisa for the detection of antibodies
WO1999060401A1 (en) Immunoassay reagents and immunoassay method
CA2221556C (en) Buffer composition for reagents for immunoassay
JP2001221802A (ja) 抗ＨＢｃ抗体の免疫測定法
EP0154392A2 (en) Processes for the detection of non-A, non-B hepatitis and a kit for use in the same
JP3487642B2 (ja) Ｈａｖ抗原及びその抗原と免疫学的に反応性の抗体の測定法
JP2001330616A (ja) 抗原結合固相の製造方法
JPH0743385B2 (ja) 梅毒抗原の製造法
JP2503358B2 (ja) イムノアッセイに使用するウイルス溶液
JP4975600B2 (ja) Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
JP3034104B2 (ja) 金属イオンの錯化剤を含有する固相免疫検定法用洗浄溶液およびその使用
Cranage et al. An indirect haemadsorption procedure (MRSPAH) for detecting antibodies to respiratory syncytial virus
CA2491918C (en) Methods for detecting or assaying virus
JPH10260187A (ja) 複数の亜型が存在する抗原の共通抗原決定基に特異的な抗体の測定法ならびに測定試薬
JPH06213895A (ja) Ｃ型肝炎の急性期の決定方法

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20050215

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20050404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050512

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20051101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060224

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20060518

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20060601

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080321

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110328

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120328

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130328

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140328

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term